Kristie M. Grebe, PhD

Chief Scientific Officer
Anokion
Cambridge, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• Pharmacodynamic Demonstration of Immunological Tolerance Induced by KAN-101, a Novel Liver-targeted Therapy for Celiac Disease

  Wednesday, June 19, 2024
  4:15 PM – 4:30 PM PT